SEC Form 4 · accession 0000318306-16-000045
ABEONA THERAPEUTICS INC. · ABEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
B Davis Jeffrey
Officer — Chief Operating Officer · Director
Period of report
Feb 11, 2016
Accepted (ET)
Feb 16, 2016 · 5:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000318306
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $2.31 | Feb 11, 2016 | A | 37,500 | A | Feb 11, 2017 | Feb 11, 2026 | Common stock | 37,500 | 37,500 | D |
| Stock option (right to buy)F1,F2 | $2.31 | Feb 11, 2016 | A | 112,500 | A | Mar 11, 2017 | Feb 11, 2026 | Common stock | 112,500 | 150,000 | D |
Explanation of responses
- F1100% accelerated vesting on change of control.
- F2After twelve months from the Grant Date options vest 2.0833% monthly. All options vested 48 months from the Grant Date.